DK242082A - Fremgangsmaade til udvinding af et middel med antineoplastisk virkning samt de aktive komponenter i dette middel - Google Patents

Fremgangsmaade til udvinding af et middel med antineoplastisk virkning samt de aktive komponenter i dette middel Download PDF

Info

Publication number: DK242082A
Authority: DK; Denmark
Prior art keywords: extraction; procedure; agent; active components; antineoplastic effect
Prior art date: 1981-07-02

Application number

DK242082A

Other languages

English (en)

Other versions

DK162813C (da

DK162813B (da

Inventor

S R Burzynski

Original Assignee

S R Burzynski

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-07-02

Filing date

1982-05-28

Publication date

1983-01-03

1982-05-28 Application filed by S R Burzynski filed Critical S R Burzynski

1983-01-03 Publication of DK242082A publication Critical patent/DK242082A/da

1991-12-16 Publication of DK162813B publication Critical patent/DK162813B/da

1992-05-04 Application granted granted Critical

1992-05-04 Publication of DK162813C publication Critical patent/DK162813C/da

Links

230000000118 anti-neoplastic effect Effects 0.000 title 1
238000000605 extraction Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
- C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/834—Urine; urinary system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK242082A 1981-07-02 1982-05-28 Fremgangsmaade til fremstilling af et praeparat til at haemme vaeksten af neoplastiske celler DK162813C (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US27972881A	1981-07-02	1981-07-02
US27972881		1981-07-02
US06/330,383 US4470970A (en)	1981-07-02	1981-12-15	Purified antineoplaston fractions and methods of treating neoplastic disease
US33038381		1981-12-15

Publications (3)

Publication Number	Publication Date
DK242082A true DK242082A (da)	1983-01-03
DK162813B DK162813B (da)	1991-12-16
DK162813C DK162813C (da)	1992-05-04

Family

ID=26959856

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK242082A DK162813C (da)	1981-07-02	1982-05-28	Fremgangsmaade til fremstilling af et praeparat til at haemme vaeksten af neoplastiske celler
DK911434A DK143491D0 (da)	1981-07-02	1991-08-06	Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK911434A DK143491D0 (da)	1981-07-02	1991-08-06	Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion

Country Status (14)

Country	Link
US (1)	US4470970A (da)
EP (1)	EP0069232B1 (da)
JP (3)	JPH0729925B2 (da)
AU (1)	AU551109B2 (da)
CA (1)	CA1188218A (da)
DE (1)	DE3273952D1 (da)
DK (2)	DK162813C (da)
ES (1)	ES8502417A1 (da)
HK (1)	HK30289A (da)
IL (1)	IL65960A (da)
MY (1)	MY102918A (da)
NO (1)	NO163595C (da)
NZ (1)	NZ200805A (da)
SG (1)	SG4489G (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4559325A (en) *	1981-12-15	1985-12-17	Burzynski Stanislaw R	Purified antineoplaston fractions and methods of treating neoplastic disease
US4593038A (en) *	1985-04-03	1986-06-03	Burzynski Stanislaw R	Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
US4705796A (en) *	1986-08-25	1987-11-10	Stereochemical Genetics, Inc.	Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
WO1991016309A1 (en) *	1990-04-12	1991-10-31	University Of Georgia Research Foundation, Inc.	Synthetic piperidinediones with cytostatic activity
US5238947A (en) *	1990-04-12	1993-08-24	University Of Georgia Research Foundation, Inc.	Synthetic piperidinediones with cytostatic activity
US5089508A (en) *	1990-09-04	1992-02-18	Burzynski Stanislaw R	Methods for treating aids
US5116622A (en) *	1990-09-12	1992-05-26	Burzynski Stanislaw R	Methods for treating parkinson's disease
EP0567613B1 (en) *	1991-10-21	2002-02-20	The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services	Compositions for therapy and prevention of cancer
US6037376A (en) *	1991-10-21	2000-03-14	The United States Of America As Represented By The Department Of Health And Human Services	Methods for therapy of cancer
US5635532A (en) *	1991-10-21	1997-06-03	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US5605930A (en) *	1991-10-21	1997-02-25	The United States Of America As Represented By The Department Of Health And Human Services	Compositions and methods for treating and preventing pathologies including cancer
IT1257184B (it) *	1992-12-22	1996-01-10	Applied Research Systems	Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
US5783605A (en) *	1995-02-27	1998-07-21	Kuo; Sheng-Chu	Helper inducers for differentiation therapy and chemoprevention of cancer
DE69734713T2 (de) *	1996-05-14	2006-07-06	Burzynski, Stanislaw R., Houston	Liposomale antineoplaston therapie mit bemerkenswert verbesserter antineoplastischer aktivität
WO1998004290A2 (en) *	1996-07-26	1998-02-05	Perrine Susan P	Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
US6258849B1 (en)	1998-07-23	2001-07-10	Stanislaw R. Burzynski	Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
US6127419A (en) *	1998-11-23	2000-10-03	Burzynski; Stanislaw R.	Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
WO2000037091A1 (fr) *	1998-12-18	2000-06-29	Chang, Ming-Lieh	Composition pharmaceutique induisant la differentiation des cellules cancereuses et leur application pour le traitement et la prevention du cancer
US6987131B1 (en)	2000-06-26	2006-01-17	Burzynski Stanislaw R	Phenylacetic acid compositions for treating or preventing hypercholesterolemia
NZ538405A (en) *	2002-08-01	2007-12-21	Aesgen Inc	Improved treatment of cancer with glutamine and carbohydrate
US20060246016A1 (en) *	2003-05-28	2006-11-02	Burzynski Stanislaw R	Toothpaste containing anticancer agents
US7087219B2 (en) *	2003-05-28	2006-08-08	Stanislaw R. Burzynski	Toothpaste containing anticancer agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE463549A (da) *
GB2003887A (en) *	1977-09-06	1979-03-21	Nyegaard & Co As	Isolation of peptides from urine
JPS57115330A (en) *	1981-01-08	1982-07-17	Toshiba Mach Co Ltd	Forming process for thick plastic products and its metal mold
JP2897285B2 (ja) *	1989-10-19	1999-05-31	東洋紡績株式会社	熱可塑性樹脂フィルム積層物

1981
- 1981-12-15 US US06/330,383 patent/US4470970A/en not_active Expired - Lifetime
1982
- 1982-05-26 CA CA000403789A patent/CA1188218A/en not_active Expired
- 1982-05-27 AU AU84239/82A patent/AU551109B2/en not_active Expired
- 1982-05-28 DK DK242082A patent/DK162813C/da not_active IP Right Cessation
- 1982-05-31 NZ NZ200805A patent/NZ200805A/en unknown
- 1982-06-03 IL IL65960A patent/IL65960A/xx not_active IP Right Cessation
- 1982-06-03 EP EP82104867A patent/EP0069232B1/en not_active Expired
- 1982-06-03 DE DE8282104867T patent/DE3273952D1/de not_active Expired
- 1982-06-07 ES ES512894A patent/ES8502417A1/es not_active Expired
- 1982-06-29 NO NO822218A patent/NO163595C/no not_active IP Right Cessation
- 1982-07-02 JP JP11533082A patent/JPH0729925B2/ja not_active Expired - Lifetime
1987
- 1987-09-29 MY MYPI87002172A patent/MY102918A/en unknown
1989
- 1989-01-26 SG SG44/89A patent/SG4489G/en unknown
- 1989-04-13 HK HK302/89A patent/HK30289A/en not_active IP Right Cessation
1991
- 1991-05-09 JP JP3133639A patent/JPH0739390B2/ja not_active Expired - Lifetime
- 1991-05-09 JP JP3133638A patent/JPH0780764B2/ja not_active Expired - Lifetime
- 1991-08-06 DK DK911434A patent/DK143491D0/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
JPH0532548A (ja)	1993-02-09
JPH0729925B2 (ja)	1995-04-05
JPH0739390B2 (ja)	1995-05-01
JPH0558886A (ja)	1993-03-09
DK143491A (da)	1991-08-06
MY102918A (en)	1993-03-31
EP0069232A2 (en)	1983-01-12
DK143491D0 (da)	1991-08-06
US4470970A (en)	1984-09-11
DK162813C (da)	1992-05-04
JPS5810521A (ja)	1983-01-21
DK162813B (da)	1991-12-16
IL65960A (en)	1985-11-29
NO822218L (no)	1983-01-03
ES512894A0 (es)	1985-01-01
NO163595B (no)	1990-03-19
CA1188218A (en)	1985-06-04
ES8502417A1 (es)	1985-01-01
NZ200805A (en)	1986-08-08
SG4489G (en)	1989-05-26
EP0069232A3 (en)	1984-07-04
DE3273952D1 (en)	1986-12-04
NO163595C (no)	1990-06-27
AU551109B2 (en)	1986-04-17
HK30289A (en)	1989-04-21
JPH0780764B2 (ja)	1995-08-30
EP0069232B1 (en)	1986-10-29
CA1262907C (da)	1989-11-14
AU8423982A (en)	1983-01-06
IL65960A0 (en)	1982-09-30

Legal Events

Date	Code	Title	Description
2002-06-10	PUP	Patent expired

Publication	Publication Date	Title
NL191640C (nl)	1995-11-20	Plasma-weergeefinrichting en werkwijze voor het bedrijven van de inrichting.
ES517764A0 (es)	1983-12-01	Procedimiento de preparacion de nuevos derivados esteroides sustituidos en 11b.
DK20979A (da)	1979-07-21	4-amino-5-alkylsulfonyl-0-anisamid-derivater samt fremgangsmaade til fremstilling deraf
DK66582A (da)	1982-08-18	Fremgangsmaade til fremstilling af carbostyrilderivater
ES512660A0 (es)	1983-07-01	Metodo de fijacion y estabilizacion de plaquetas.
DK446082A (da)	1983-04-22	Fremgangsmaade til fremstilling af chlordioxid samt apparat til anvendelse derved
DK491582A (da)	1983-05-10	Fremgangsmaade til fremstilling af morphinanderivater
DK352082A (da)	1983-02-08	Fremgangsmaade til fremstilling af ergopeptinderivater
DK369483A (da)	1984-02-14	Stabiliseret herbicidsammensaetning samt fremgangsmaade til fremstilling af samme
DK453982A (da)	1983-04-24	Fremgangsmaade til fremstilling af oligosaccharidderivater
ES515375A0 (es)	1984-04-01	Procedimiento para la preparacion de derivados de 3-piridilo y 2-piracinilo.
DK160555C (da)	1991-09-16	Fremgangsmaade til fremstilling af eburnamoninderivater
ES519869A0 (es)	1984-04-16	Procedimiento y dispositivo para la limpieza de piezas individuales mecanizadas.
DK275582A (da)	1982-12-25	Depotorgan til frigivelse af biologisk aktive stoffer til fordoejelseskanalen samt fremgangsmaade til anvendelse heraf
NO153757C (no)	1986-05-21	Fremgangsmaate for hurtigavkjoeling av smeltet metalloksyd samt apparat for gjennomfoering av fremgangsmaaten.
DK70482A (da)	1982-08-20	Fremgangsmaade til fremstilling af diazolderivater
DK570082A (da)	1983-06-26	4-cyan-2-azetidinoner samt fremgangsmaade til fremstilling af saadanne
DK164288C (da)	1992-12-28	Maskinopvaskemiddel paa basis af chlorisocyanuratderivat samt fremgangsmaade til fremstilling af et saadant middel
DK7483D0 (da)	1983-01-10	Fremgangsmade til fremstilling af 6-aminoalkylpencillansyre-1,1-dioxider samt derivater deraf
DK157036C (da)	1990-03-26	Endo-deoxyribonuklease a samt fremgangsmaade til fremstilling af samme
DK86979A (da)	1979-09-03	Substituerede pyrrolidinoner med herbicid virkning samt fremgangsmaade til fremstilling af saadanne forbindelser
ES517428A0 (es)	1983-08-16	Procedimiento de preparacion de derivados bencilidenicos.
DK281485A (da)	1985-12-24	Fremgangsmaade til ekspansion af tobak samt middel til anvendelse derved
DK150482A (da)	1982-10-09	Fremgangsmaade til fremstilling af formlegemer af polylaurinlaktam samt de derved fremstillede formlegemer
ES512600A0 (es)	1983-06-01	"metodo para la determinacion de la actividad de las isoenzimas citoplasmaticas y mitocondriales de la transaminasa glutamico-oxalacetica en suero o plasma humano".